Thank you to everyone who attended our webinar ‘Antibodies to watch in 2026‘ in association with the journal, mAbs. Below are ...

If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...

A team of theoretical researchers has found duality can unveil non-invertible symmetry protected topological phases, which ...

While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...

Chemical, biological, radiological, nuclear and explosive substances (CBRNE substances for short) can pose a threat to the ...

Fabrice Chouraqui, Chief Executive Officer of Pharming, commented: ...

To the rescue: periodization training. Put simply, periodization training is an intentional exercise program with “strategically fluctuating variables like volume, intensity, speed, and weight,” says ...

More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...

Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...

Getting your Trinity Audio player ready... A new phase of the $200 million Cherry Creek North redevelopment is underway, as construction begins on 250 Clayton, an eight-story, 175,000-square-foot ...

Critical Hartford and Connecticut business news updated daily. Immediate access to all subscriber-only content on our website. Bi-weekly print or digital editions of our award-winning publication.